FineHeart
PrivateLast Round
Series C
Jan 9, 2026
Total Funding Raised
$75.41M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
FineHeart operates in Healthcare & Life Sciences and is based in Pessac. Its latest recorded funding round was a Series C round in January 2026.
FineHeart is a medical device company that develops the FLOWMAKER®, a wirelessly powered, fully implantable mechanical circulatory support device for patients with severe heart failure.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FineHeart Comparables
Compare FineHeart with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CorWave | 89% | |
| BrioHealth Solutions | 85% | |
| Evaheart, Inc. | 85% |
For institutional investors. Book with your work email.
FineHeart Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 9, 2026 | ||||
| Grant | Oct 19, 2022 | ||||
| Series B Extension | Dec 15, 2021 | ||||
| Series B | Jun 1, 2021 | ||||
| Series A | Mar 21, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
FineHeart Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Series C |
| Verve Ventures | Series B Extension, Series B |
| European Commission | Grant |
| Verve Capital | Series C |
| Aqui-Invest | Series A |
| Groupe Pasteur Mutualité | Series C |
| UI Investment | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 24, 2026
Open roles increased to 49, 5.2x the trailing average.
- Feb 1, 2026
Monthly visitors grew 191% MoM, reaching 2.6K.
For institutional investors. Book with your work email.
FineHeart Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about FineHeart's valuation, stock price, and market status.
Is FineHeart a public or private company?
FineHeart is a private company.
What is the current stock price of FineHeart?
FineHeart is a private company, so its shares have no public market price. Caplight tracks FineHeart's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is FineHeart worth (valuation)?
Valuation information for FineHeart is not publicly available.
Can I buy FineHeart stock?
FineHeart shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was FineHeart's last funding round?
FineHeart's most recent funding round was Series C on January 9, 2026.
Who are the main investors in FineHeart?
Key investors in FineHeart include Doliam, Broadview Ventures.
Will FineHeart IPO soon?
No public IPO plans have been announced for FineHeart.
How can I track FineHeart secondary market activity?
Caplight tracks bids, offers, and trades in FineHeart's shares on secondary markets.